Resveratrol also demonstrated potential in a lung fibrosis experimental model by reducing inflammatory and fibrotic signaling pathways such as Toll-like receptor 4 (TLR4)/NF-κB and TGF-β1/smad3, but also by modulating epithelial–mesenchymal transition (EMT) [19,20,21]. Here, TGFB1 is linked to pulmonary fibrosis.